Engaged patients will devote more time and effort to their health, which produces better outcomes and helps research facilities cut costs and resources. To ensure that treatment decisions result in meaningful outcomes, the Veristat clinical trial design should be thought of and developed with the patients in mind. Therefore, patient participation is essential since it improves the patient’s health outcomes. Additionally, by lowering the number of readmissions and patient no-shows. and this will require less time and resources. in turn, it helps lower operational expenses for healthcare facilities. To match their study protocol with pertinent patient outcomes, sponsors, CROs, and doctors can use several patient engagement tactics, which are covered in this article.

Personalize your interactions

Segmenting your patient base is the most vital and first patient interaction technique. Patients can be divided into groups according to their age, gender, geography, medical history, diagnosis, and health insurance, during the clinical trial planning stage. You can develop engagement tactics and communications that are specifically tailored to each patient category by using segmentation. Targeting female patients would be preferable if you wanted to send your patients a leaflet about the value of mammography in detecting cancer in its early stages. By doing so, you may increase engagement rates and make your message more meaningful and pertinent to the patient.

Invest in informed consent

To assist patients in making informed decisions about their health, clinical research must incorporate the principles of health literacy. Additionally, unclear permission and health forms could mean sponsors and CROs spend more time and money leading to lost productivity and income while jeopardizing patient and doctor trust.

Streamline patient-reported outcomes

The search for significant results continues after a patient has been recruited in a trial. To get the most accurate results, sponsors and CROs must determine what keeps patients participating in the trial and giving correct data over time. Clinicians can achieve better regulatory approvals as well as drug labeling by involving patients in the design of ePROs. They can also learn new facts about the severity of a condition, keep track of patients’ live statuses, and deliver timely care catered to each patient’s particular needs. Stronger health results for both trial operators and patients are the result of all these advantages.

Actively seek patient feedback

Clinical research aims to enhance patient care and health results. Due to poorly chosen outcomes, faulty data collection, or underpowered trials, many trial results do not transfer to clinical advantages for patients. Misalignment between study protocols and important outcomes can lead to time-consuming changes that can add up to more days of development time and end up costing sponsors more money. Patients can offer crucial advice on protocol design and recruiting techniques that improve health outcomes and prevent expensive revisions from occurring, even though they may not be medical professionals. Consider adding patient-led roles to your clinical team that gathers and converts patient feedback into trial outcomes if you want to incorporate patient feedback into the design of your studies.

Whether you’re operating an in-person, hybrid, or fully virtual trial, our flexible solutions keep you in full control. Build your study in a matter of days so you have more time to focus on what matters—your patients and their health outcomes.